Z-Medica
Z-Medica is a medical device company that develops FDA-cleared kaolin-based hemostatic products (QuikClot®) for controlling severe bleeding in hospitals, EMS, law enforcement, and military settings. Operating as a subsidiary of Teleflex Incorporated, it sells through direct B2B enterprise and government channels globally.
- Company typePrivate
- Founded2002
- HeadquartersWallingford, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Z-Medica firmographics
Firmographics- Name
- Z-Medica
- Legal name
- Z-Medica
- Website
- https://z-medica.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Z-Medica is a medical device company that develops FDA-cleared kaolin-based hemostatic products (QuikClot®) for controlling severe bleeding in hospitals, EMS, law enforcement, and military settings. Operating as a subsidiary of Teleflex Incorporated, it sells through direct B2B enterprise and government channels globally.
- Ownership category
- akta.pro rank
Z-Medica industry classification
Industry- Product category
- Hemostatic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)
Keywords
Where Z-Medica is headquartered
LocationHeadquarters
- HQ city
- Wallingford
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Z-Medica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Hemostatic Medical Devices: Sale of QuikClot branded hemostatic products including Combat Gauze, QuikClot Control+, and Interventional devices for bleeding control in medical, military, and emergency response settings.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Z-Medica product offering
Product offeringCore offering
Z-Medica manufactures and sells QuikClot branded hemostatic medical devices—kaolin-impregnated gauze dressings, hemostatic pads, and interventional products—that activate Factor XII to accelerate the clotting cascade and achieve faster bleeding control. Products are sold for hospital (OR, Cath Lab, ICU, ED), EMS & fire rescue, law enforcement, and military use. Federal (USA) law restricts sale or use of these devices to physicians or by the order of a physician.
Product overview
Z-Medica's QuikClot is a portfolio of proprietary kaolin-based hemostatic products designed to control bleeding faster than standard methods. The core technology consists of a non-woven material impregnated with Kaolin, which activates Factor XII and accelerates the clotting cascade. The product line includes QuikClot Control+ (hospital hemostatic dressing), QuikClot Combat Gauze (military/tactical gauze), and QuikClot Radial (cath lab device), serving four market segments: Hospital (OR, Cath Lab, ICU, ED), EMS & Fire Rescue, Law Enforcement, and Military. Clinical evidence demonstrates 88-92% faster time to hemostasis and up to 39% less blood loss compared to standard care.
Differentiator
Problem solved
Functional benefit
Brands
- QuikClot®: Proprietary hemostatic agent technology using kaolin-impregnated material to accelerate clotting and control bleeding faster.
Products and services
- QuikClot Control+® A kaolin-based hemostatic dressing indicated for hospital bleeding control, shown in clinical studies to achieve up to 39% less blood loss compared to standard care. For use by or on the order of a physician.
- QuikClot Combat Gauze® A kaolin-impregnated gauze bandage used by military and first responders for hemorrhage control in traumatic injuries, with 95% successful hemostasis reported in the Mayo Clinic Prehospital study and 91% in the Israeli Defense Forces study.
- QuikClot Radial® A kaolin-based hemostatic pad designed for transradial access procedures in catheterization labs, demonstrating savings of 89 minutes versus TR band compression and 17 minutes versus manual compression.
- QuikClot Interventional® QuikClot interventional hemostatic products intended for catheterization lab use, leveraging the kaolin-based technology to accelerate hemostasis after percutaneous procedures.
Quantifiable outcome
- 88%-92% faster time to hemostasis compared to standard gauze
- +4 more outcomes
Companies that use Z-Medica
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Z-Medica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Z-Medica partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Stop The BleedcoreZ-Medica is an official partner of the Stop The Bleed program, a national initiative that trains civilians in bleeding control. The partnership supports public safety education and extends QuikClot's reach to broader community bleeding control awareness.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Z-Medica competitors and assessment
Company assessmentDirect peers
- Celox Medical: Celox manufactures chitosan-based hemostatic gauze and granules used by military and emergency responders for rapid bleeding control. Direct competitor to QuikClot in prehospital and tactical hemostasis, addressing the same combat and trauma applications with a different active mechanism.
- Tricol Biomedical (HemCon): Tricol Biomedical produces HemCon chitosan-based hemostatic dressings and bandages used in military and civilian trauma care. Directly comparable to QuikClot Combat Gauze as a competing hemostatic technology marketed to the same military, EMS, and law enforcement buyers.
Broad incumbents
- Baxter International: Baxter markets FloSeal hemostatic matrix and other surgical hemostasis products used in operating rooms and hospitals. A broad incumbent medical device company competing in surgical hemostasis with overlapping OR and cath lab customer relationships.
- Ethicon (Johnson & Johnson): Ethicon manufactures Surgicel oxidized cellulose hemostatic products used across surgical specialties. As a J&J surgical franchise, it competes with QuikClot for hospital OR and surgical hemostasis share through established surgeon relationships and formulary presence.
- Integra LifeSciences: Integra LifeSciences offers a portfolio of hemostasis products including oxidized cellulose and collagen-based agents sold to hospitals and surgical centers. A diversified medtech incumbent with overlapping surgical hemostasis sales channels.
- Becton Dickinson (BD): BD provides hemostatic and tissue sealing products, along with surgical instruments, sold to hospitals and surgical centers globally. Large incumbent with broad hospital channel reach comparable to the buyer set served by QuikClot's hospital line.
- Teleflex Incorporated: Teleflex is Z-Medica's parent company and a global medical technology company with vascular access, surgical, and anesthesia portfolios. Relevant as the corporate owner controlling QuikClot strategy and as a broad incumbent providing commercial scale in overlapping hospital markets.
- Medtronic: Medtronic operates broad surgical, vascular, and patient monitoring franchises that touch the same OR, cath lab, and ICU buyers served by QuikClot's hospital products. While not a direct hemostatic gauze competitor, it is a broad incumbent with overlapping hospital decision-maker relationships and channel access.
Emerging players
- Marine Polymer Technologies: Marine Polymer Technologies develops poly-N-acetyl glucosamine based hemostatic dressings for wound and bleeding control. An emerging player with overlapping hemostatic technology but more limited commercial scale than QuikClot's installed base.
- Arch Therapeutics: Arch Therapeutics develops self-assembling peptide-based hemostatic and sealant products (AC5) for surgical and trauma use. An emerging player with a novel mechanism targeting the same hemostatic use cases served by QuikClot in OR and trauma settings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Z-Medica social profiles
Digital presenceZ-Medica compliance and trust
Trust signalCompliance3 records
Z-Medica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Z-Medica leadership team
Management profileNumber of profiles
Profiles2 records
Z-Medica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Z-Medica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Z-Medica
What does Z-Medica do?
Z-Medica manufactures and sells QuikClot branded hemostatic medical devices—kaolin-impregnated gauze dressings, hemostatic pads, and interventional products—that activate Factor XII to accelerate the clotting cascade and achieve faster bleeding control. Products are sold for hospital (OR, Cath Lab, ICU, ED), EMS & fire rescue, law enforcement, and military use. Federal (USA) law restricts sale or use of these devices to physicians or by the order of a physician.
Is Z-Medica a public or private company?
Z-Medica is a private company. It is classified as corporate owned and is currently operating.
When was Z-Medica founded?
Z-Medica was founded in 2002. It employs 51 to 100 people.
Where is Z-Medica based?
Z-Medica is headquartered in Wallingford, United States, in the North America region.
How does Z-Medica make money?
One revenue line is on record: hemostatic Medical Devices.
Who are Z-Medica's main competitors?
Direct peers on record are Celox Medical and Tricol Biomedical (HemCon). Broad incumbents are Baxter International, Ethicon (Johnson & Johnson), Integra LifeSciences, Becton Dickinson (BD), Teleflex Incorporated and Medtronic. Emerging players are Marine Polymer Technologies and Arch Therapeutics.
Does Z-Medica have an API?
No public API is recorded for Z-Medica.
What industry is Z-Medica in?
Z-Medica's product category is Hemostatic Medical Devices. Its primary akta.pro industry code is HLAHADAL, Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets). Its NAICS code is 339113 and its SIC code is 3841.